You are here

AusPAR: Ad26.COV2.S

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

25 June 2021
AusPAR Details
AusPAR
Active Ingredient
Ad26.COV2.S
Product Name
COVID-19 Vaccine Janssen
Sponsor
Janssen-Cilag Pty Ltd
Submission Number
PM-2020-06173-1-2
Submission Type
New biological entity
Decision
Approved for provisional registration
AusPAR Date
25 June 2021
Publication Date

25 June 2021